Reducing Opioid Use for Chronic Pain Patients Following Surgery
Recruiting now NCT03675386
Run by University Health Network, Toronto · for 18 and older · All sexes
What this study is about
Patients with chronic pain are often prescribed long-term opioid therapy, despite the serious risks and growing concerns related to opioid use. The Toronto General Hospital has created the world's first multidisciplinary perioperative Transitional Pain Service Program (TPSP) aimed at reducing the incidence and severity of chronic post-surgical pain. The TPSP incorporates a variety of mechanisms and interventions to help patients manage pain and to wean off opioids. The approach consists of: pain education, Acceptance and Commitment Therapy (ACT), and an e-mobile self- management tool to help patients manage chronic pain more effectively. With the TPSP team, the investigators hope to continually assist patients to achieve a balance between the benefits and potential harms of opioid use to promote long-term health and well-being.
Who can join (things the study team will check)
✅ You may be able to join if…
- ≥ 18 years of age
- Taking 10 -- 400 mg of preoperative oral morphine equivalents daily
- Any type of surgical procedure, with the exception of those with palliative intent or organ transplantation
- Able to read and understand English as posed on the questionnaire surveys prior to informed consent
- Must be taking opioids for at least one month prior to their operation
- Must have a personal email address for the set-up of the Manage My Pain (MMP) App or online multimedia tool
🚫 You may not be able to join if…
- Subjects who are undergoing palliative care or procedures, organ transplantation, or prescribed with Methadone/Buprenorphine will be excluded from the trial
Where this trial is running
- Toronto General Hospital- University Health Network, Toronto, Ontario, Canada
Who to contact
Karim Ladha, MD · 416-719-0030 · Karim.Ladha@uhn.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT03675386.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.